Results of a study of the quality of life in patients with highly active multiple sclerosis in Russia-Reference-Cited by-同舟云学术

Results of a study of the quality of life in patients with highly active multiple sclerosis in Russia

Published:2022-08-03 Issue:1S Volume:14 Page:9-15
ISSN:2310-1342
Container-title:Neurology, Neuropsychiatry, Psychosomatics
language:
Short-container-title:RJTAO

Author:

Boiko A. N.¹^ORCID,Bakhtiyarova K. Z.²^ORCID,Sherman M. A.³^ORCID,Goncharova Z. A.⁴^ORCID,Smagina I. V.⁵^ORCID,Khaibullin T. I.⁶^ORCID,Babicheva N. N.⁶^ORCID,Spirina N. N.⁷^ORCID,Yampolskaya-Gosteva I. A.⁸^ORCID,Sokolova I. A.⁹^ORCID,Greshnova I. V.¹⁰^ORCID,Nikitenkova V. E.¹¹^ORCID,Lukashevich I. G.¹²^ORCID,Inzhinova A. V.¹³^ORCID,Malkova N. A.¹⁴^ORCID,Korobko D. S.¹⁴^ORCID,Boyko O. V.¹⁵^ORCID,Lozovskaya I. S.¹⁶^ORCID

Affiliation:

1. Department of Neurology, Neurosurgery and Medical Genetics, N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia; Institute of Clinical Neurology, Federal Center for Brain and Neurotechnologies, Federal Medical and Biological Agency of Russia

2. Bashkir State Medical University, Ministry of Health of Russia

3. Kirov State Medical University, Ministry of Health of Russia

4. Rostov State Medical University, Ministry of Health of Russia

5. Altai State Medical University, Ministry of Health of Russia

6. Republican Clinical Neurological Center

7. Yaroslavl State Medical University, Ministry of Health of Russia

8. Orenburg Regional Clinical Hospital

9. “MEDIS” LLC

10. Ulyanovsk Regional Clinical Hospital

11. Smolensk State Medical University, Ministry of Health of Russia

12. Chelyabinsk City Clinical Hospital №1

13. Volgograd Regional Clinical Hospital №3

14. Novosibirsk State Regional Clinical Hospital

15. Institute of Clinical Neurology, Federal Center for Brain and Neurotechnologies, Federal Medical and Biological Agency of Russia

16. Russian Committee of Multiple Sclerosis Researchers

Abstract

Multiple sclerosis (MS) is a chronic autoimmune inflammatory demyelinating and neurodegenerative disease of the central nervous system. Now 2.8 million people in the world suffer from MS, since 2000 every 5 years there has been an increase in the number of MS patients by 10%. At the same time, the number of cases with highly active MS (HAMS) is increasing, i.e. cases of MS with two or more exacerbations without taking specific pathogenetic therapy or one exacerbation during taking MS disease-modifying therapies (DMTsMS), which is accompanied by the corresponding MRI data of the brain and spinal cord (presence of new or active lesions). Previously, there were no studies of quality of life (QoL) in this subgroup of patients in the world.Objective: to compare the QoL indicators of patients with HAMS with those of healthy people and patients with a typical course of relapsingremitting MS (RRMS).Patients and methods. The study included data on 518 patients from 14 regions of the Russian Federation for 2020–2021 years, in whom HAMS was confirmed during a second examination. We used the results of the analysis of clinical data from neurologists and data from questionnaires filled out by patients with HAMS. Two questionnaires were used in the work – the general (non-specific) Questionnaire for assessing the QoL, SF-36 (The MOS 36-item Short-Form Health Survey) and a special questionnaire for MS patients – MusiQoL (Multiple sclerosis Quality of Life).Results and discussion. Almost all indicators of QoL in HAMS were below the control. When compared with the typical course of RRMS, a more pronounced decrease in daily activity indicators, a significant impact of clinical symptoms on QoL, a negative attitude of patients towards the healthcare system, and a low overall health index were noted. Pearson correlation analysis revealed a stronger effect on QoL parameters of the frequency of exacerbations in HAMS than in RRMS.Conclusion. The data obtained in the study indicate the need for more active management of patients with HAMS using second-line DMTsMS.

Publisher

IMA Press, LLC

Subject

Psychiatry and Mental health,Neurology (clinical),Clinical Psychology

Reference14 articles.

1. Balyazin VA, Goncharova ZA, Rudenko OYu. Faktory, vliyayushchie na kachestvo zhizni bol'nykh rasseyannym sklerozom. Sovremennye problemy nauki i obrazovaniya. 2012 Okt 16;(5):56. Dostupno po ssylke: https://scienceeducation.ru/ru/article/view?id=7160 [Balyazin VA, Goncharova ZA, Rudenko OYu. The factors which influence the multiply sclerosis patients’ quality of life. Sovremennyye problemy nauki i obrazovaniya. 2012 Oct 16;(5):56. Available from: https://scienceeducation.ru/ru/article/view?id=7160 (In Russ.)].

2. Boiko OV. Issledovanie kachestva zhizni bol'nykh rasseyannym sklerozom. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. Spetsvypuski. 2014;114(10-2):105-13. [Boyko OV. Quality of life in patients with multiple sclerosis (a review). Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 2014;114 (10-2):105-13 (In Russ.)].

3. Fasczewski KS, Rothberger SM, Gill DL. Why do they do it? Assessing self-report physical activity behavior and quality of life in individuals with multiple sclerosis. J Health Psychol. 2020 Jun;25(7):964-75. doi: 10.1177/1359105317739965. Epub 2017 Nov 27.

4. Fiest KM, Greenfield J, Metz LM, et al. Discriminative ability of quality of life measures in multiple sclerosis. Health Qual Life Outcomes. 2017 Dec 21;15(1):246. doi: 10.1186/s12955-017-0828-0

5. Simeoni M, Auquier P, Fernandez O, et al; MusiQoL study group. Validation of the Multiple Sclerosis International Quality of Life questionnaire. Mult Scler. 2008 Mar;14(2):219-30. doi: 10.1177/1352458507080733. Epub 2007 Oct 17.